| Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis RS Taylor, RJ Taylor, S Bayliss, H Hagström, P Nasr, JM Schattenberg, ... Gastroenterology 158 (6), 1611-1625. e12, 2020 | 717 | 2020 |
| Inhibition of hepatitis B virus expression and replication by RNA interference A Shlomai, Y Shaul Hepatology 37 (4), 764-770, 2003 | 486 | 2003 |
| Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase S Ben-Shlomo, I Zvibel, M Shnell, A Shlomai, E Chepurko, Z Halpern, ... Journal of hepatology 54 (6), 1214-1223, 2011 | 363 | 2011 |
| Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up S Zelber-Sagi, R Lotan, A Shlomai, M Webb, G Harrari, A Buch, ... Journal of hepatology 56 (5), 1145-1151, 2012 | 332 | 2012 |
| CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus V Ramanan, A Shlomai, DBT Cox, RE Schwartz, E Michailidis, A Bhatta, ... Scientific reports 5 (1), 10833, 2015 | 323 | 2015 |
| Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems A Shlomai, RE Schwartz, V Ramanan, A Bhatta, YP de Jong, SN Bhatia, ... Proceedings of the National Academy of Sciences 111 (33), 12193-12198, 2014 | 267 | 2014 |
| Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients N Shafran, I Shafran, H Ben-Zvi, S Sofer, L Sheena, I Krause, A Shlomai, ... Scientific reports 11 (1), 12703, 2021 | 183 | 2021 |
| Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma A Shlomai, YP de Jong, CM Rice Seminars in cancer biology 26, 78-88, 2014 | 183 | 2014 |
| Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens S March, V Ramanan, K Trehan, S Ng, A Galstian, N Gural, MA Scull, ... Nature protocols 10 (12), 2027-2053, 2015 | 163 | 2015 |
| Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1α MM Rechtman, O Har-Noy, I Bar-Yishay, S Fishman, Y Adamovich, ... FEBS letters 584 (11), 2485-2490, 2010 | 152 | 2010 |
| A broad RNA virus survey reveals both miRNA dependence and functional sequestration TKH Scheel, JM Luna, M Liniger, E Nishiuchi, K Rozen-Gagnon, ... Cell host & microbe 19 (3), 409-423, 2016 | 135 | 2016 |
| PGC-1α controls hepatitis B virus through nutritional signals A Shlomai, N Paran, Y Shaul Proceedings of the National Academy of Sciences 103 (43), 16003-16008, 2006 | 122 | 2006 |
| Acute liver failure is regulated by MYC-and microbiome-dependent programs AA Kolodziejczyk, S Federici, N Zmora, G Mohapatra, M Dori-Bachash, ... Nature medicine 26 (12), 1899-1911, 2020 | 112 | 2020 |
| Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression I Bar‐Yishay, Y Shaul, A Shlomai Liver International 31 (3), 282-290, 2011 | 109 | 2011 |
| The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1 Y Adamovich, A Shlomai, P Tsvetkov, KB Umansky, N Reuven, JL Estall, ... Molecular and cellular biology 33 (13), 2603-2613, 2013 | 107 | 2013 |
| Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells E Billerbeck, MC Mommersteeg, A Shlomai, JW Xiao, L Andrus, A Bhatta, ... Journal of hepatology 65 (2), 334-343, 2016 | 86 | 2016 |
| AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease N Peleg, A Issachar, O Sneh-Arbib, A Shlomai Digestive and Liver Disease 49 (10), 1133-1138, 2017 | 78 | 2017 |
| Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load N Peleg, A Issachar, OS Arbib, M Cohen-Naftaly, M Braun, M Leshno, ... JHEP Reports 1 (1), 9-16, 2019 | 75 | 2019 |
| A robust cell culture system supporting the complete life cycle of hepatitis B virus E Michailidis, J Pabon, K Xiang, P Park, V Ramanan, HH Hoffmann, ... Scientific reports 7 (1), 16616, 2017 | 73 | 2017 |
| The “metabolovirus” model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon A Shlomai, Y Shaul Medical hypotheses 71 (1), 53-57, 2008 | 57 | 2008 |
